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FRYAUFF ETA L. ('I al., 1989) , Indonesia (Baird et al., 199 1b; Schwartz el al., 1991 ) , India (Garg el al., 1995) , and Gu yan a (Craig and Kain, 1996) . International travel, which has becom e mu ch easier and m ore frequent over the last four decades, may figure more imp ortantly in facilitating the geographi cal spread of C Q -resista nt P. ,·jvax (C Q RPV) th an it did in spreading CQ-rcsistant P. [alcipannn (C Q RP F) in the 1960s.
D et ailed , confirma tive stu d ies of C Q RPV have been relatively few, and efforts to track th e geographical sprea d of thi s pr obl em have been largel y co nfined to the Indonesian archipe lago -a popul ou s nation of so me 140, 000 islands. Am ong all of th ese islands, Ni as, in north-western Sum atra, drew early attenti on as one of the first areas on the planet th ought to be affec ted by C Q RPV. As Nias draws large numb ers of int erna tional to urists to its antiquities and surfers to its waves, it was apparent that there was a great risk o f resistant strains of m alarial parasite on th e island bein g carried all over th e globe . F ollowing on th e case rep ort of C Q RPV in a repatriated Am erican to urist who acqu ired his infection on Nias (Schwartz et al. , 1991 ) and co nfirm ation of th is C Q RPV at the Ce n ters for Dise ase Con trol and Preventi on , in At lanta (C ollins et al., 1992) , in-vivo field testin g of CQ sensitivity/res ista nce was co nducted in early 1995 (Baird er al., 1996) . The results of thi s first survey reveal ed C Q resistance, to suppressive levels, in 33% of the P. oiuax investigated , with parasitaemi as recurring, within 19 days of supe rvised th erapy with C Q of good qu ality, in 14 % (Baird el al. , 1996) . The ma in aim of th e pre sent study, co nd ucted 3 years late r at the same site, was to re-asse ss the se ns itivity of local P. viwax to CQ ill vivo, to det ermine whe ther the frequ en cy and degree of C Q resistan ce had measurably increased since the first survey . At the sam e time, the efficacy, in vivo, ofsulfad oxine-pyrirue th am ine (SP) -the se co nd-line therapy for uncomplicat ed P.
[alcip aru nt infecti on -and the risk o f m alarial infection faced by a joint Am ericanIndonesian military exe rcise planned for the area were evaluated.
MATERIALS AN D M ET H O DS
Study S ites a n d Subjects All-age m alaria screenings we re co ndu cted in five rural co m m unities (L agun d ri, Walondrawa, Bot ohilitan o, Hilinifaoso and Hili am aet aniha) aro und the port of T eluk D alarn , on the sou thern coast of N ias Island , be tween the Ju ly and September of 1998. Ni as covers an area o f 56 25 km ".
Passive case dete ction was also p erformed, on a da ily bas is for 3 weeks (1-2 1 August 1998 ), through the health clin ic at Lagundri, which covers all five study co mmunities. M ost of the resident s in the area have occupations that are agricultural (rice cultivation, patchouli cultivation and perfume-o il processing ) or associated with tour ism . The popularity of Legundri as an inte rnatio nal to uristfsurfing des tination h as created an increasing demand for lod gin g, food and othe r service s. T ourist lodgings, rest aurant s and hou sin g for Indonesian fam ilies and workers have proliferated on the land between th e rice paddies, m angrove fore st and beach, with faciliti es ranging from extremely inexpensive/bas ic to we stern -style, 'five-s tar' luxury . 1 \ 1any yo ung touri sts app ear to opt for ve ry sim ple and affo rdable, longerterm lod ging in traditional-style bunga low s. Mosquito coi ls and untr eated bednets are widely used by both local resid ent s and tourists. CQ, SP and quinin e are the respectiv e first-, second-and third-line drugs for mal aria treatment in the Indon esian N ation al H ealth Serv ice and all are locally available in the sho ps .
S c reen ing a n d Enrolment Indi viduals with un complicat ed , slideconfirme d m alaria wh o we re age d > 4 years, abl e to swa llow pills, not pr egn ant and wh o had not consum ed antim alarial drug s or ant ibio tics in the previou s week were invit ed to vo lunteer for malaria treatm ent in the co ntext of a 28-day , in-vivo test. Written, inform ed co nsent \vas ob taine d from eac h volunteer or the voluntee r's paren t/gu ardian .
This consent included an assurance th at th e volu ntee r agreed (1) to use no ot he r drug or treatmen t b ut those provide d and supervised by th e research ers, (2) to su bm it to d aily sym pto m evalua tio ns and fingcrp ricks, and (3) to sub mit to venip unc t ure for cas es of P. uiuax th at reappeared wit hin 2 1 d ays of receiving C Q . An enro lm ent of 38 1'. uiuax cases wa s sough t, based u pon th e proportion of C Q RPV previous ly reported ( 14% ; Baird er al. , 1996 ) , and th e aim to estimate th e new proporti on, with 90% co nfidence , to be within 10 perce n tage points of the true value (Lcrneshowand T aber, 1991 ) . W ith no previous measu re of clinical or therapeut ic resistance to 5 1' in the local P. fa kiparuni, it was arbitrarily assu me d th at treatment failure would occur in 25 % of cases (th e critica l level above whi ch an alternate treatment d rug wo uld be advised ) . W ith 90 % co nfide nc e and 10(% precision , th e de sired samp le size for testing the sensitivity of local P. falcipa rtnn to SP wa s the n estima te d to be 5 1 infecti on s (Le m eshow and T ab er, 199 1) . Ind ivid uals with par asitaerni a who de clined to en ro l or who were excluded from en rolme nt were provided wit h free treatment and follow-u p, according to the local sta nda rd o f care.
C h e m o t he r a py a n d FoUow-up Each sub jec t with P. cioax infection was given a total of 25 mg C Q base (ResochinT.,,; PT Bayer, Jakarta, Indonesiaj/kg body weight, as three oral d oses of 10, 10 and 5 rug/kg 0, 24 and 4 8 h afte r rec ruitme n t (i.c, d ays 0, I and 2), resp ectiv ely. The sub jects with P. [alcipannn infection were eac h given a sing le ora l d ose of SP (Fansid ar " ; Roch e, Base l, Switzerland) -just on e tablet (cont aining 500 mg sulfad oxine and 25 mg pyrimethamine) if they weighed 15-19.9 kg, and 1.5, 2.0, 2.5 and 3.0 tablets if they weighed 20-29, 30 -39, 40-49 and > 50 kg, respectively. All the tabl ets were co ns u m ed after a sma ll snack of sweet biscuits and water and each treatment was witnessed by a member of the st ud y team. Ph ysical co mplaint s and axillary tempera ture \' vere recorded and fingerp rick blood sam ple s (for thi ck and thin blood sm ears) were co llec ted on d ays 0-4, 7, II , 14, 18 , 21 and 28 and also at any time of illness indi cative of ma laria. The blood smc ars were stained with Giemsa and exa m ined b y oil-immersion , light microscopy (at x 1000 ) by a skilled m icroscopi st. Each thi ck smear was exa m ined for m alari al par asit es and only co nsidered ne gati ve if no parasit es were see n in 30 0 field s. Sexu aland asex ua l-stage parasites were separately counted against 20 0 leucocytes and each count wa s then multiplied by 40 to give an estim ate of the numbe r of pa rasitcs/ul blo od (assu ming eac h sub ject had 800 0 leucocytcs/ul ) .
Al iq uots (I 00 ul ) of fingerprick bloo d ob ta ine d on day 0, 2 and any tim e of suspecte d treatment failu re were co llected onto filte r pap ers, labelled and air dri ed for subseq ue nt use in ana lysing blood co nce ntration s o f C Q or th e parasite geno type (sec below). U n re mi tti ng pa rasitae rnia or reapp earan ce of asex ua l parasites d uring th e 28-day pe riod of th e in-v ivo test co nsti tuted a treat ment failu re. The clinical sym ptoms of malaria, with parasi taernia tha t did not resolve following treatme nt or wh ich recurred with parasitaernia, during the 28-day. followup period, cons tituted a cli nic al failure. In acc ordance with nati onal he alth policy in In d onesia, any C Q and SP failures observed were given ora l qui nine for 7 days, as rescue treatment . Cu mulative indices of therapeu tic ( parasito logical) and clinical failu re for ea ch Plasm odium species and d ru g trea tment were calculated using the life- . I \ l ea s u r c ln cn t o f Blood C o nccn t r a ti o ns of CQ C Q and its pri ncipal metabolite , monode sethylchloroquine (D CQ) , were extracted, from the filter-paper blots o f the wh oleblood sam ples of tho se tre ated with C Q , so 
Plasmodiurn falciparurn
Parasite D NA was extracted, from the filterpap er blots of the whole -b lood samples of those treat ed wi th SP, usin g 5%) Chelex-IOO resi n (Bio-Ra d Labo ratories, Hercules, CA) in distilled wat er and then purified through an A72 1C mini colum n (Prornega, M ad ison WI ) . T he D NA was th en amplified using the nested-P f.R method described by N agesh a er al. (200 1), the ap p rop riate po sitive and neg ative co ntrols (to minim ize the risk of contamination error in the first and second rounds of the peR), and co nve ntional primers and those speci fic for the resistan ceassociated mut ation s in the parasite's dhfr or dhp s genes (O urasingh et at. , 1998) . The dhfr and dhps polymorphisms we re id ent ified b y RFLI' (restriction-fragm en t-lengthpolym orphism ) ana lysis. The nest ed am plificat ion products of dhfr were digested with Nla IIl, Tall, Tsp509 I , X1//1/1 and [)l' al , for discriminating the alleles at cod on s 16, 50, 5 1 and 164, whereas codo n 108 was selectively cleaved wit h AIII I, RSI'I and SerF!. The dhps PC R prod uc ts we re dig ested with iV/spA ll, Avail and Fok l fo r the identification of mu tation s at co do ns 436,437 and 540 , B. <tU I and B sII for th e id en tification of those at codon 58 1, and AlztloI, BsaW! and Agel for the identifi cation of those at codon 6 13. As a control to munitor the end 0 -nu clease diges tion, purified lambda DNA (P rornega) was used in eac h RFLP exp erimen t. D igested produ cts we re subjected to electrop horesis on 1.5%-3% , aga rose gel , or ultrapure agarosc gel (Progcn, Darra, Au stralia) for enhanced resolution . The PCR prod ucts of interest we re seque nc ed according to p ublished method ology (W ang et al., 1997 a, b), to verify the RF LP results and to ide ntify any ne w mu tation sites in the dhfr and dhp s product s.
A ssessm e n t of Transmission by M osquitoes M osquitoes we re capt ured o utdoors in eac h of the five study co mmunities, betw een 18. 00 and 23 .00 hours, as they landed o n the memb ers of a two-man team equipped with flashlight s and aspirators. Anophelines were sorte d, ident ified to species and stored dried over silica gel until their heads and thoraces could be tes ted in an E LIS A for Plasmodium sporozo ites (\Xlirtz et al., 1985 (\Xlirtz et al., , 1992 . 1 \l onoclo nal antibodies for Pifalcipan un and the circums porozo ite variants of P. v ivax (V K24 7 and PV2 1O) wer e em ploye d in t he E LIS A. The en to mo logical data were used to produce estimates of the man-biting rate (bites/person-night) and the entomological inoculation rate (infective bites/person-month) assuming that the local mo squit oes only fed du rin g th e collect ion period (18.0 0 -2 3.0 0 ho urs ) and that all the m osquitoes tha t land ed on the hum an bait wou ld have fed on the bait.
RES U LTS
Malarra Prevalence by Location and Age-group All -age active case d etec tio n (A C O) , co nducte d in July-Augu st 1998, identified malarial par asitaern ia in 122 ( 17.2%) of the 7 10 peo ple screened and revealed comm unityspecific point prevalences ranging from 6%) to 4 0 1 % (T able 1) . M alarial parasitacmi as, all of w hich we re low-density, were fou nd in 
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27 (8.6%) of th e 314 appa rent ly asym ptomatic schoolchild ren (aged 6-13 years) screened; six ( 1.9%) appeared to have pure P. fa lciparunt infectio ns whereas th e other 2 1 (6. 7%) appeared to have pure P. ".'h'ax infections. Passive case detection (PC D) , over 3 weeks in th e Lagundri hea lth clini c, co nfinned malaria in 77 (44.8%) of th e 173 cases judged to be of 'clinica l m alar ia' by local healthcar c provid ers. The co nfirm ed cas es appea red to be in fected with P. [alcipan nn only (47 case s), with 1'. vicax only (28 cas es) or a mix ture of th ese two species (two cases). For both P. ' i..' i'iJa x and P. falciparum. th e age distributions of th ose found pos itive by ACD differed markedly for th ose found positive by PCD (Fig. I ). Children aged < 6 year s, for exam ple, acc ounted for 23 'Y o of the infections found by ACD screening but made up only SI X, of th e co nfirm ed clinical malaria cases in the P C D (1'= 0.007 ) . D espite the high freq uency of infection seen in the children sc reened during th e ACD and the predominance of child ren in the demography of th e population (77% of the residents of the stu dy co m m unities were aged < 16 years at the tim e of enrolment), ad ults (aged > 15 years ) made up 52 t X, of the d iagn osed cases of clinica l m alari a in the ACD and accounted for 4 3% of th ose CO l1-finned by mic ros cop y in th e PCD . In the PCD, th e olde r chi ld ren and young ad ults (i.e. th ose aged 6 -40 years) wer e twice as likely to be co nfirme d positive by microscopy as those wh o we re younge r o r olde r) with a relative risk (RR) of 2.14 and co rresponding 95% confidenc e interva l (C I) of 1.30 -3.54 .
E ffi ca cy of the CQ Treatment of Ptasrnodiurn vivax In fec ti on Illness at enro lme nt -most com mo nly hea dache (76%) , fever (68%) , malaise (44%), nausea (·10%) an d muscle pain (24%) -was reported by 26 of the 36 subj ects with P. virax infection and eight were found to be febrile (i.e. with an axillary temperaturẽ 3 7 . 5 C ) . The cha racteristics of cas es wh o recei ved C Q treatment and remain ed available for all or most of follow-up peri od are pr esented in Table 2 . The co rresponding therapeutic and clinical responses are summarized in Figure 2 . Baseline ( pre-treatment) concentration s of C Q + DCQ in three of th e 30 subjects tested ranged from I 13-639 ng/rnl, ind icating recent previou s treatm ent and /or pot entially resistant infec tions. All parasitaernias declin ed rapidl y in respon se to th e C Q trea tment given as part of thc present stud y and cleared by 96 h . The me an parasit e-clearan ce time was 36 .7 h, with C I of ± 5.6 h . Illness aba ted in th e m ajority of the subjec ts by 72 h, with only three of 35 still rep oning he ad ach e or nau sea at that lime . The first rea ppearance of asexual parasites following th erap y and clearance was o n day 11. in two asymptomatic children. These 1W O children , who had had 7280 and * Blood samples collected from 30 of the subjects at enrolme nt revea led that seven of th e 30 th en had detectable blood co ncentrat ions (22-6 33 ng-ml ) ofCQ plus its metabolite rnonod cscth ylchloroquine (D C Ql , and that thr ee of th e seven had > 100 ng C Q + DCQ 'ml.
"Seven of th e 22 sub jects chec ked had detect able blood co ncentrations of C Q +-D CQ on day 28, thr ee ha ving > 100 ngml at that rime .
t O ne of the six subjects checke d o n th e-day of recurrence ha d > 100 ng C Q + DCQ 'm l.
Efficacy of the SP Treatment of Plasrnodiurn folciporum In fectio n Symptom s -most commonly headache (94%) , fever (8 1%), m alaise (72%), nausea (56%), and vomiting (37%) -were reported at enrolment by 33 of th e 39 subject s with P. falcipa nnn infection although only 1-1 (36%) were found feb rile at that time. The geometric mean (G :\ I) P. falcipannn pa rasitacmia before trea tment (on day 0) was 10 times higher [han th e corresponding P. riocx parasitaernia (T able 2). In general, t he clinical and therapeut ic resp on ses to SP we re poor. At the d ay-3 (72 h) follow-up, fever had resolved in 13 of th e 14, initially febrile cases b ut 47 % an d 24 % of all th ose given SP were still complaining of headache and malaise, respectivel y. Asexual pa ra sitaernias declined by > 25 % within 48 h o f treatment in 34 cases (o f the 38 providing the relevant data) and had clea red by day 4 (96 h) in 28 of the 39 cases. U nremitting R1II-o r Rll-typ e responses within 7 days of trea tment characteri zed, respectively, four (I 1%) and I I (29%) of th e SP trea tments. Two of the subjects treated with SP withdrew from follow-up and th ree o thers were di s-enro lled between days 7 an d 11 because of intercurrent P. V iVdX infection . F igu re 2 illustrat es the cu m ulative inci dence of clinical and the rapeut ic failu res over th e 28 days following S P trea tmen t. the rapeu tic failures occ urred during th e first 11 d ays, with tr eatment success ac hieved in only six of th e 35 ease s wh o p rovid ed sufficient d ata . The frequency of gam et ocyte ca rriage an d th e G l\1 densit y of th e gamctocytae rnias observed inc rease d progressively ove r th e firs t 7 da ys following SP trea tment (F ig. 3) . Retrospective mole cular ana lyses, to d etermine wh ether allelic mutations in th e dhps and dhfr genes of the infecting parasit es could ha ve predi cted SP treatment ou tcome, were pe rformed on 2 7 cas es wh o had be en graded S, RI , RII or RIll . Sequencing o f th e p eR pr oduct s revealed that dhps co do ns 43 6, 437 , 581, and 6 13 we re all normal wild -t ype and that mu tati on s in th is gene had not arisen or been selec ted for. Although seq ue ncing of dhfr identified point m utation s only at cod ons 108 and 59 , th ese m u ta tions were d ete ct ed in 26 (96%) and 2 1 (78%)) of the 27 cases, respectively, with 20 cases eac h having th e d ouble mutati on . There was no apparent asso ciatio n between the frequen cy or pa tte rn of these dhf r mutation s and th e in-vivo resp on se Cr able 3); th e d ouble mutatio n, for exa mple, was see n in each of th ree sensitive (S) infecti on s as we ll as in th ree RIll treatm ent failures. The sing le infecti on that was wild-type at all dlifr co do ns appea red to recrudesce on d ay 11 post-treatment . A comparison of th e day-O and d ay-7 dhfr pr ofiles of eac h of nine cases demon strating RIl-or RIll-type resistan ce showed the Arg59 and Asn I08 d ouble mutati on at both tim e-poin ts. Quinine rescu e th er ap y was successful fo r all o f the SP treatment failu res. were found to be carryi ng spo rozoi tes. The sporozoite 'rate" was therefore 0.8 % for all of the Anopheles tested and 1.2% for th e A ll. sundaicus. Sin ce th e mean biting rate for all Anopheles was 6.8 bit es/personnight, the entomo logical inoculation rate was (co nservatively) estima ted at 1.6 infective b ites/person -m on th (T able~) .
Ma la ria T ransmissi on

DISC USSION
The princ ipa l aim of the prese nt study was to initiate period ic, in-vivo re-testin g, to de tect any cha nge in th e fre que ncy of C Q Rl'V at an Ind onesian site where th is tra it had been first recogni zed an d co nfirmed (Sch wartz er al., 1991 ; Collins <' I aI., 1992 ) . The present investigation, co nd uct ed 3 year s after the first su rvey for C Q RPV o n N ias (Baird et al., ) 996), does not provid e any evid ence o f such a change . Althou gh the p resen t results inclu de clear indication s of P. 'V;V QX resista nce to both sup pressive and th erapeu tic co ncen tra tio ns of C Q, th ey show no grea ter freq uency of such resistance than that reported for the same site in 1995 (Baird et al., 199 6 ) . The C Q -lOleran t or C Q-resist an t 
·111~· cod ons of isolates collected from this pa tient on da y (1 and t he da y of recurren ce were compared (and found to be id ent ical ).
'J'ABLE :L 'J ' h~' pveoatcnces lIt" ill/~'aioll >: ..Assuming all bit es occur each n ight on ly during the 'i-h peri od ( 18 .00 -2 3.00 h ours) when the land ing catches were made and that 311 landing rno squirocs would ha w bit ten th e human bait . st udy were also found in the pre sence of C Q + D CQ co nc en trations sim ilar to th ose d etect ed in 1995 (Baird 01 al. 1996) . It is unclear wh y, given th e ap paren tly equ al se lective pressure applied world-wid e to P. viua x and P. [alcipurnnr by CQ use and mis-u se, CQRPV is much less common th an C Q RP F. This may be rel ated to the obse rvation that CQ-scnsitive P. oivax can be killed b y a d ose of C Q that is only abo u t a qu arter of th e dose ne eded to kill C Q -se nsi tive P. [alciparum (Berliner 01 aI., 194 8) . The CQ resist an ce in P. fal ciparum has been shown to be cent rally de pe nde nt up on a po int mutation (K 76n in a single gene ( pf m ) co d ing for a transpo rt protein in membrane of th e parasit e's digestiv e vac uo le (F id ock (1 al., 2000) . This point mutati on was present in eve ry clinical case of C Q RP F studied in M ali b y Djimde 01 al. (200 1) and in 9 3% of the C Q RP F case s stud ied in Papua, Indonesia, by M aguire 01 al. (200 I). Alth ough a gen e ort ho log present in P. uiuax ( p'vcg I 0) is remarkabl y sim ilar to pfcn in terms of its position , com pos ition and struc ture, no point mutati ons th at d istinguish CQ-sen sitivc and C Q -rcsiswnt ph en otypes of P. ciua» have been found in pucgl O(N o m ura Cl al., 2001 ) . The apparent molecular divergence in the C Q-resista nce strategies of P. falciparum and P. viuax is in contrast to th e co m mo n mechanism o f ant ifolate resistan ce see n in all th e mal ari al parasites o f rodents and human s investig ated (D e Pecoulas ct al., 1998 ; Carlto n 01 al., 200 1) .
The present results d o no t warr an t increased concern about CQRPV o n Nia s or m ore frequent m onitoring of CQRPV on th e island. H owever , the poor clin ical and therapeutic effects of SP on local Pi fa lcipannn and th e almost ubiquitous occu rrence o f dhfr mutat ions co nferri ng pyrimethamine resistance in these par asites arc worrying. The freq uency of SP treatment failure obse rve d on N ias is among th e highe st reco rde d in Indonesia -even excee ding th ose recorde d o n Papuan In d onesia (Baird et al., 1991a; Tjitra 01 al., 199 7 ; N age sh a 01 al., 200 1) -and meet s th e World H ealth Organ izat ion's criterion for a cha nge in the an tima laria l drug used (W H O , 1994 ) . All 74 cases fro m cen tral and nonhero Sumatra wh o were tested i ll V itl{l between 1981 and 1985 d em on strated sens itivity to SP , although in-vitro testing over the same period and in the sam e locations sho wed SP resistance in 28 of 38 isolates (T iitra 01 al., 19 97). A rapid ch ange in the sens itivity o f P. [alcipa rum to pyrimethamine and SP was obse rved in north-east ern Papuan Indonesia (H offm an 01 aI., 1985 , 198 7; Baird 01 al., 199I a) , altho ugh resist ance to pyrime tha mine and cross -resistance to p roguanil evo lved ea rly and progressed rapidly there, as a res ul t of th e m ass dist ribution of pyri me rha mi nizcd salt in 1959 -1 960 (M cuwissen, 1961 ) . Interestingly, th e ca mpa ign to di stribute and promote th e use of th is med icat ed salt m ark edl y reduced the preval en ce o f P. vivax and P. nratariac m alaria, with pyrimethamine remaining effective as both a treatment and prophylactic agains t P. cioax at a time of increasing resistance in P. [alcipan tm (M cuwisscn, 1964 ) . There ap pears to be no record of th e use of pyrirnetharninizcd salt on Xi as. Resistan ce to C Q in P. faiciparum and high freq uenc ies of gametocyte ca rria ge in chi ld ren pr ompted he alth o llicials and resear chers to ado pt SP pl us primaquine for th e routine trea tme nt of m alari a in coastal north Sumat ra during a co m m uni ty health project in 1985 -1 989. Alth ou gh th is coope rative (Indonesian-Japanese) programme led to a m ark ed reduction in the prevalen ce of P. falcipanun infection, there was littl e change in P. oioax, de spit e the combine d usc of chemo the rapy, bednets and larvi ciding (D o i 01 al., 1989) .
The results of th e present analyses of dhfr and dhps in P. falciparum fro m Nia s ar e singular in d em on strating no evide nce of any mu tati on in the dhps ge ne associated with SP resistance. The non-involvemen t of dhps point mutat ion s ap pears not to have been reported before in any area we re the re were such high freq uencies of SP treatment failure . The dhps mutat ion at position 437 is a co mmonly reported marker of sulfadoxine pressure 20 0 I) and 6 2%, of malar ia-immune na tive Papuan s (H . S . Na ges ha, unpubl, obs .) ; both significant ly lower p roportions tha n the frequen cy of Asn I08 in the present samples from N ias (9 6%) . In co n t ras t to th e present results fru m Ni as, th e P. [alciparnni in th e sym p to matic, non-immune immigrants from Papuan Indon esia com mo nly exp resse d point mutation s in the dlips gene at co dons 4 37 (8 3%) and 54 0 (47%) , altho ug h " lips mutation s (at p ositi on 4 37 in 24 %, an d at pos itio n 54 0 in 5 %) were see n far less fre q ue n tly in th e parasites from th e asym pto m atic infections in th e nati ve Papuans (H . S. Nagesha, unpub!. obs.) . It see ms possible th at dhps mu tation s pla y a re latively small role in SP resist an ce (or co nfer a relatively sma ll adva n tage in term s of th e pa ras ite's su rvival ) unde r co nd itions of low transmi ssion int en sity.
A recently reco nside red problem is the potential fo r 5P treatm ent to exacerbate co m m u n ity levels of P. [a lcipartnn t ra nsmi ssion, by elevating the prevalence and inten sit y o f ga rnc tocyta cm ias. This d isad vantage of SP ha s alread y been reported in Asia (Tin and N yunt Hlaing, 1984; Marworo "I al., 1986) and much d ebat ed (Ittiravivo ngs et al., 1984 ; Strickland et al., 1986; Baird el al., 199I e) . Among th e nonirnrnuncs in north-eastern Papuan Ind on esia who were given SP in 1996 -1 998, as a resc ue treatmen t foll owing C Q failure, th e prevalenc e o f garnetocytaernia rose fro m 0% to 43 % within 7 da ys, with th e GJ\\ int en sity (amo ng th ose who were ga merocy tae mic ) peaking, on d ay 14, at 19 9 gam et ocytes/ul (C I = I 53-2 77 lfLi ; unp ub!. obs. ) . H owever, the gameto cyte resp on se obse rve d in N ics, where the pre valen ce of gam ctocytaem ia rose fro m 26 % to 7 3 %, within 7 da ys and th e pea k G i\\ int en sit y wa s 44 5 gamcto cyte s/u l (C I = 282-700Ipl) on d ay 7, was sign ifica ntly higher. In co mpariso n, on an isolat ed island off north-western Papuan Indon esia, whe re all th e P. [alcipan un ap peared Sl'-sen siti ve, ga rne tocy tes wer e see n in only four of 40 cases between da ys 0 and 7 and in only 12 of 288 smea rs p repared later in th e follow-up, and th en always at low d ensities (Fryauff et al., 1999) . No atte m pt was made to d eterm ine the viabili ty and infectivit y o f th e ga me tocytes in the elevated gamc tocy tae rn ias ap pa ren tly induced by S P tr eatmen t on Ni as, but these gametocyt es m ay we ll be viabl e and sim ilarly resist ant to the spo ro n ticidal ac tivity of 5P (Bu tcher, 1997 ; Robert et al., 2000) . T he ea rly ap pearance o f the garnc to cytacrnias, soon after SP treatment , has been ta ken as an ind ication tha t the gam etocytcs seen, man y of which arc immature and non-infecti ve, ha ve no t been induced by th e tr eatmen t but merel y mo bilized or re-di stributed from sites whe re they have been seques te re d (T argett et al., 200 1) . Whil e th e pyrimeth amineme di at ed mobiliza tion or d evelopment o f ga rnetocytc s (C h urm ongkon kul et al. 1992) on Ni as m ay h ave been enhanced by mutations in the d/~fr gene , it also see ms possibl e th at the ab sence of mutations assoc iat ed with sulfad oxinc resistance in dhps m ay ha ve somehow stim ulated gamctocytogenes is (Bu tcher, 199 7; H ogh el al., 1998) .
T he p resent d em onstration of P. uioax sporozoites in All. sundaicns and th e d ominance of this mosq uito species among the man -bi tin g ano p he lincs co llecte d we re not un expected in the coas tal stu dy area. Anopheles sundaicus is conside red to be th e d ominant vec to r of both P. oioax and P. [alcipanun over m uch of coas ta l Indon esia (Im ai t!t al. , 1988) and is respon sible for the per sisten ce of m alari a along the so ut hern coast of Java de spite the successful elim inat ion of m alaria from most of this island (Atm oesod iono et al., 1992) . A nopheles tesselatus is a confirmed vector of P. on-ax an d P. fukipa n nn in sou th ern Asia (G arn age-M en d is et al. , 199 3) and was previous ly th e only confirmed vec to r of malari al parasit es on Ni as (Ind ones ian M inist ry of H ealth, u npub!. obs . al., 1998) . The potential for P. uiuax transm ission by Au. sinensis deri ves m ainly fro m the high de nsities th at population s of this species ca n attain CRee et ol., 200 1). T he present co llect ions of m osqu itoes on N ias we re lim ited in sam p ling tim e, season and locat ion and therefore pro bably bi ased . ANopheles tcsselatus, An. sinensis and ot he r fres hwa ter-breeding an ophclincs undetected in the brief survey on coasta l Nias may be m ore ab un dant inland, whe re th ey m ay play a m ore import ant role in m alarial tr ansmi ssion .
In summary, act ive case de tection identified large numbers of asym ptomatic infecti ons and garnetocytae rnias, predo m inant ly amo ng young child ren, in the rura l populati on of southe rn, coa stal Nias. No evidence was found of in creasing resistan ce to C Q in th e local P. cieox at th is co n firmed foc us of C Q RP V but th e results of in-vivo testing de mo nst rated poor thera pe utic an d clin ical respon ses to SP in P. falciparuni. There was a high frequen cy of m utation s in the dhfr ge ne that arc associated with pyrim ethamine resistance in P. falciparum, but no sign of selection pressure by sulfado xine in the dhps gene. In add itio n to its poor clin ical performance, 5 P ap peared to increase th e frequen cy an d intensity of garne tocytac mias, po tentially height ening malaria transmission and disease risk in th e area. Alth ou gh C Q still affords goo d treat m ent efficacy aga inst P. virax on Ni as, the use of 5 1' alon e in the treatment of P. falcipanun on th e islan d sho uld be stro ngly di scouraged . SP sho uld on ly be used in co mbi na tio n wit h a rapidly acting and garn etocytocid al arre m isinin derivative (K um ar and Zheng, 1990; Price el al., 1996) . In Africa, the cost of treatmen t with a co mbina tio n of SP and artes una te is curre nt ly rep orted to be U .S.$ 1.30 mo re th an th e cost of SP alone (which is be low U .S.$0. 20 ) and beyond th e reach of 1110st of th ose with m alaria (Vick, 2002) . In Indonesia , however, the cos ts of SP p lus artcsuna te m ay be m an ageabl e, especially if th ey could be reduced greatly by in-co untry production of Artemisia a111wa. Even tho ugh most isolates of P. falcipa nun from N ias appear resistant to treatment wit h C Q an d SP, th e use of a co m bination of C Q and SP might offer some ad vantage over the use of eithe r C Q o r SP as a first-line strategy aga inst unco mplicated, P.Jalciparum ma laria 
